ABBV: חובות מצטברים של החברה AbbVie

AbbVie Inc. (ABBV) maintains its leadership by replacing expired patents with innovative medicines, although debt loads from mergers and regulatory pressure create financial risks. Total liabilities on this chart demonstrate the balance of credit leverage, where 0.00 becomes the new value of the indicator. The high cost of unique biologics allows the company to exercise pricing power, ensuring exceptional business profitability.

This indicator tracks the total amount of borrowed funds, determining the financial burden on the business's capital. Investors utilize the total debt metric to analyze solvency and assess default risks. The line's trend reflects the balance between leverage and operational stability. For AbbVie Inc. (ABBV), this is critical when maintaining a network of high-tech plants in the US and Europe. Effective debt management ensures the development of complex biopharmaceutical production.